STEPUPIORS PI from BRFAA Dr Ieronymos Zoidakis visited IORS on June 07, 2024, for a second regular expert partner visit. During the visit, Dr Zoidakis got acquainted with the newly acquired equipment and biobanking facilities of the Department of Experimental Oncology. The visit was hosted by Dr Ana Đurić, Dr Marko Radulović and Aleksandra Stanojević.
Dr Zoidakis discussed on the available infrastructure and equipment important for successful activities within WP2, with a focus on the first Luminex® MAGPIX® system in Serbia that was donated to IORS by STEPUPIORS’ stakeholder company Novos d.o.o. This excellent example of collaboration between academia and industry will enable IORS to try out a simple, cost-effective medium throughput multiplexing of Merck MILLIPLEX® immunoassays on plasma samples of patients with locally advanced rectal cancer. Profiling of predictive biomarkers for the purpose of selection of patients who might benefit from the watch and wait approach enabling their higher quality of life will be performed as a part of project activities in WP2. Validation of the results is planned on prospectively collected samples from the first Serbian rectal cancer biobank in 2025.
Dr Zoidakis also participated as a chair and speaker at the VII Symposium of the Serbian Protomics Society (SEPA) “Proteomics Application in Biomedicine” held at the Serbian Academy of Arts and Sciences in Belgrade on June 06, 2024.
